United States· US:66215-910_7c54a125-9778-41f5-b92c-181711e22e06

UPTRAVI

A medicinal product containing selexipag, registered in United States by Actelion Pharmaceuticals US, Inc..

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedUPTRAVIATC—REGISTER NO.US:66215-910_7c54a125…PACKS LISTED2CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
SELEXIPAG
Manufacturer
Actelion Pharmaceuticals US, Inc.
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    66215-910-14
  • ndc11
    6621591014
    1 BOTTLE in 1 CARTON (66215-910-14) / 140 TABLET, FILM COATED in 1 BOTTLE

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Selexipag in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All selexipag products

Authorised across Europe · EMA

The same active substance is authorised in 19 EEA countries. Names it is sold under:

  • Austria · Selexipag Ratiopharm
  • Cyprus · Selexipag Accord
  • Denmark · Selexipag Accord, Selexipag Stada
  • Estonia · Selexipag Stada
  • Spain · Selexipag Accord, Selexipag Stada
  • Greece · Xipeno
  • Croatia · Seleksipag Accord
  • Ireland · Selexipag Accord, Selexipag Clonmel
  • Iceland · Selexipag Stada, Uptravi
  • Italy · Selexipag Accord, Selexipag Eg
  • Liechtenstein · Uptravi
  • Lithuania · Selexipag Stada
  • Latvia · Selexipag Stada
  • Malta · Selexipag Clonmel
  • Netherlands · Seleksipag Accord, Selexipag Abdi
  • Norway · Selexipag Accord, Selexipag Stada
  • Poland · Selexipag, Selexipag Accord
  • Portugal · Selexipag Accord, Selexipag Teva
  • Sweden · Selexipag, Selexipag Accord

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f44af65b-5c7c-4554-8b39-2e42d7b799f9
GET /v1/drugs/f44af65b-5c7c-4554-8b39-2e42d7b799f9?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "100",
  "substance": "SELEXIPAG",
  "productndc": "66215-910",
  "dosage_form": "TABLET, FILM COATED",
  "dea_schedule": null,
  "strength_unit": "ug/1",
  "application_number": "NDA207947",
  "marketing_category": "NDA"
}

See everything about selexipag.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.